| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $258.0M | — | -9.2% |
| Cost of Revenue | $141.6M | — | -17.0% |
| Gross Profit | $116.4M | — | +2.6% |
| R&D Expense | $6.7M | — | -13.0% |
| SG&A Expense | $40.7M | — | -5.6% |
| Pre-tax Income | $30.2M | — | +12.7% |
| Income Tax | $6.8M | — | +7.9% |
| Net Income | $59.8M | — | +191.7% |
| EPS (Basic) | $1.70 | — | +203.6% |
| EPS (Diluted) | $1.66 | — | +196.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $95.4M | +22.2% | +33.4% |
| Inventory | $203.6M | +9.5% | -17.0% |
| Current Assets | $581.8M | +28.1% | +9.8% |
| Total Assets | $1.65B | -0.1% | -19.7% |
| Current Liabilities | $409.4M | +20.0% | +54.7% |
| Long-term Debt | $1.08B | -6.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.0M | — | -107.9% |
| Investing Cash Flow | $106.3M | — | +1024.3% |
| Financing Cash Flow | -$61.8M | — | -461.8% |
| -18.8% |
| Total Liabilities | $1.61B | -0.6% | -11.5% |
| Stockholders' Equity | $38.9M | +31.0% | -83.4% |